-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Oom2RSAWl10w2+6VI7Pc30p+ijBWkYV/X1FC8MdDwwj5lPRZ/dbYXvjv/BQj3Nyy 9XZwzo9rSFJelQSYjJpwRg== 0001185185-04-000105.txt : 20040607 0001185185-04-000105.hdr.sgml : 20040607 20040607154651 ACCESSION NUMBER: 0001185185-04-000105 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040607 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COMMONWEALTH BIOTECHNOLOGIES INC CENTRAL INDEX KEY: 0001042418 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 541641133 STATE OF INCORPORATION: VA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-51823 FILM NUMBER: 04851928 BUSINESS ADDRESS: STREET 1: 601 BIOTECH DRIVE CITY: RICHMOND STATE: VA ZIP: 23235 BUSINESS PHONE: 8046483820 MAIL ADDRESS: STREET 1: 601 BIOTECH DRIVE CITY: RICHMOND STATE: VA ZIP: 23235 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DSAM GLOBALVALUE FUND CENTRAL INDEX KEY: 0001120163 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: C/O GOLDMAN SACHS TRUST STREET 2: HARBOUR CENTER NORTH CHURCH ST. CITY: GEORGETOWN CAYMAN IS STATE: E9 ZIP: 00000 BUSINESS PHONE: 6617915127 MAIL ADDRESS: STREET 1: C/O GOLDMAN SACHS TRUST STREET 2: HARBOUR CENTER NORTH CHURCH ST. CITY: GEORGETOWN CAYMAN IS STATE: E9 ZIP: 00000 SC 13D 1 dsam13dcombio.txt DSAM 13D 060704 - -------------------------------------------------------------------------------- SEC 1746 POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION (11-02) CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER. - -------------------------------------------------------------------------------- ------------------------------ OMB APPROVAL ------------------------------ OMB Number 3235-0145 Expires: December 31, 2005 Estimated average burden hours per response ........ 11 ------------------------------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* COMMONWEALTH BIOTECHNOLOGIES, INC - -------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK - -------------------------------------------------------------------------------- (Title of Class of Securities) 202739108 - -------------------------------------------------------------------------------- (CUSIP Number) Angelica Morrone, DSAM Fund, LP North Church Street, PO Box 896 Grand Cayman, Cayman Islands, BWI Tel: (649)941-8144 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) May 28, 2004 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss. 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 202739108 - -------------------------------------------------------------------------------- 1. Name of Reporting Persons. I.R.S. Identification Nos. of above persons (entities only). DSAM FUND, LP (foreign entity, no IRS identification numbers) ------------------------------------------------------------------- - -------------------------------------------------------------------------------- 2. Check the Appropriate Box If a Member of a Group (See Instructions) (a) [ ] ---------------------------------------------------- (b) [ ] ---------------------------------------------------- - -------------------------------------------------------------------------------- 3. SEC Use Only ---------------------------------------------------- - -------------------------------------------------------------------------------- 4. Source of Funds (See Instructions) Investment Funds, normal course of business ------------------------------------------------------------ - ------------------------------------------------------------------------------ 5. Check If Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e) [ ] ----------------------------------------------------------------- - -------------------------------------------------------------------------------- 6. Citizenship or Place of Organization CAYMAN ISLANDS --------------------------------- - -------------------------------------------------------------------------------- 7. Sole Voting Power 305,100 --------------------------------- NUMBER OF SHARES _________________________________________________________________ BENEFICIALLY OWNED BY 8. Shared Voting Power None EACH --------------------------------- REPORTING _________________________________________________________________ PERSON WITH 9. Sole Dispositive Power 305,100 ---------------------------- ----------------------------------------------------------------- 10. Shared Dispositive Power None --------------------------- - -------------------------------------------------------------------------------- 11. Aggregate Amount Beneficially Owned by Each Reporting Person 305,100 ------------ - -------------------------------------------------------------------------------- 12. Check Box If the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] - -------------------------------------------------------------------------------- 13. Percent of Class Represented by Amount in Row (11) 9.53% ----------------- - -------------------------------------------------------------------------------- 14. Type of Reporting Person (See Instructions) ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------ ------------------------------------------------------------ - -------------------------------------------------------------------------------- SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. June 7, 2004 - ---------------- Date /s/ Angelica Morrone - ----------------------------------- Signature Angelica Morrone, Investment Manager - ------------------------------------- Name/Title The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of the filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement: provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001) -----END PRIVACY-ENHANCED MESSAGE-----